PHIBRO ANIMAL HEALTH CORP Insider Trading Activity
Every SEC Form 4 insider transaction reported for PHIBRO ANIMAL HEALTH CORP (PAHC), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are PAHC insiders buying or selling?
In the last 12 months, PHIBRO ANIMAL HEALTH CORP insiders reported 1 open-market purchase ($317.7K) and 32 sales ($29.8M) — net selling of $29.5M. Since February 2018, Trabud has recorded 93 Form 4 filings for PAHC: 5 buys ($752.8K) and 88 sells ($76.8M).
Source: SEC EDGAR Form 4
What stands out
- The largest open-market purchase in the last 12 months was $317.7K by Thomas E Corcoran (Director) on Jun 2, 2026. SEC ↗
- The most recent open-market purchase was reported on Jun 2, 2026 (4 months ago).
Key Statistics (February 2018 – Jun 2, 2026)
Total Form 4 filings
93
SEC EDGAR
Insider filers
6
Insider buys (5)
$752.8K
Insider sells (88)
$76.8M
Insider sentiment
Net sellingNet insider flow of $76.0M in net selling since February 2018, and $29.5M in net selling over the last 12 months.
Recent PAHC insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jun 2, 2026 | Thomas E Corcoran | Director | Purchase | 10.0K | $31.77 | $317.7K | SEC ↗ |
| May 7, 2026 | Jack Bendheim | President and CEO | Sale | 18.6K | $54.61 | $1.0M | SEC ↗ |
| Apr 30, 2026 | Jack Bendheim | President and CEO | Sale | 21.1K | $53.86 | $1.1M | SEC ↗ |
| Apr 23, 2026 | Jack Bendheim | President and CEO | Sale | 21.1K | $54.79 | $1.2M | SEC ↗ |
| Apr 17, 2026 | Jack Bendheim | President and CEO | Sale | 21.1K | $56.89 | $1.2M | SEC ↗ |
| Mar 31, 2026 | Jack Bendheim | President and CEO | Sale | 14.1K | $53.75 | $756.8K | SEC ↗ |
| Mar 27, 2026 | Jack Bendheim | President and CEO | Sale | 21.1K | $55.21 | $1.2M | SEC ↗ |
| Mar 19, 2026 | Jack Bendheim | President and CEO | Sale | 22.9K | $52.40 | $1.2M | SEC ↗ |
| Mar 16, 2026 | Jack Bendheim | President and CEO | Sale | 5.3K | $48.91 | $258.2K | SEC ↗ |
| Feb 27, 2026 | Jack Bendheim | President and CEO | Sale | 21.1K | $52.27 | $1.1M | SEC ↗ |
| Feb 23, 2026 | Jack Bendheim | President and CEO | Sale | 14.1K | $50.84 | $715.8K | SEC ↗ |
| Feb 19, 2026 | Jack Bendheim | President and CEO | Sale | 14.1K | $51.68 | $727.6K | SEC ↗ |
| Feb 11, 2026 | Jack Bendheim | President and CEO | Sale | 72.2K | $51.77 | $3.7M | SEC ↗ |
| Feb 9, 2026 | Jack Bendheim | President and CEO | Sale | 110.8K | $48.38 | $5.4M | SEC ↗ |
| Feb 6, 2026 | Jack Bendheim | President and CEO | Sale | 13.2K | $41.39 | $545.5K | SEC ↗ |
| Feb 2, 2026 | Jack Bendheim | President and CEO | Sale | 13.5K | $40.11 | $540.0K | SEC ↗ |
| Jan 27, 2026 | Jack Bendheim | President and CEO | Sale | 1.2K | $40.55 | $50.1K | SEC ↗ |
| Jan 23, 2026 | Jack Bendheim | President and CEO | Sale | 27.8K | $41.82 | $1.2M | SEC ↗ |
| Jan 15, 2026 | Jack Bendheim | President and CEO | Sale | 14.1K | $40.31 | $569.8K | SEC ↗ |
| Jan 13, 2026 | Jack Bendheim | President and CEO | Sale | 213 | $40.16 | $8.6K | SEC ↗ |
| Jan 8, 2026 | Jack Bendheim | President and CEO | Sale | 328 | $40.09 | $13.1K | SEC ↗ |
| Dec 10, 2025 | Jack Bendheim | President and CEO | Sale | 4.8K | $40.10 | $192.8K | SEC ↗ |
| Dec 4, 2025 | Jack Bendheim | President and CEO | Sale | 7.0K | $41.00 | $288.6K | SEC ↗ |
| Dec 2, 2025 | Jack Bendheim | President and CEO | Sale | 7.0K | $42.10 | $296.4K | SEC ↗ |
| Nov 26, 2025 | Jack Bendheim | President and CEO | Sale | 12.3K | $43.97 | $541.7K | SEC ↗ |
Showing the 25 most recent of 93 Form 4 filings for PHIBRO ANIMAL HEALTH CORP.
Most active PAHC insiders
- Jack Bendheim54 filings
- BFI Co., LLC19 filings
- Daniel M Bendheim8 filings
- Thomas E Corcoran5 filings
- Dean J Warras4 filings
Ask anything about PAHC insider activity
Use Trabud's AI agent to query PHIBRO ANIMAL HEALTH CORP's Form 4 history in plain English — "Show me PAHC CEO purchases this year" or compare it against any other ticker.
Open the AI agentPAHC insider trading FAQ
Are PHIBRO ANIMAL HEALTH CORP insiders buying or selling?
In the last 12 months, PHIBRO ANIMAL HEALTH CORP insiders reported 1 open-market purchase ($317.7K) and 32 sales ($29.8M) — net selling of $29.5M. Since February 2018, Trabud has recorded 93 Form 4 filings for PAHC: 5 buys ($752.8K) and 88 sells ($76.8M). Over the full record that is net selling of $76.0M.
How many insiders trade PAHC stock?
6 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for PHIBRO ANIMAL HEALTH CORP. The most recent filing was accepted on Jun 2, 2026.
Where does Trabud get PAHC insider trading data?
All PAHC insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.